News

Investing.com -- Chipotle Mexican Grill (NYSE: CMG) is signaling a 3.5% pre-market rebound ahead of Wednesday’s open after Minnesota health officials confirmed they have no ongoing concerns with the chain. The official clearance offers the clearest exoneration yet following Tuesday’s 9.72% plunge — the stock’s steepest single-day drop in nine months. The recovery stems from an August 5 SEC filing in which Chipotle revealed that the Minnesota Department of Health (MDH) had completely cleared it o

A source close to the matter told Reuters there is "no deal" and there "never was a deal to be done" between the two drugmakers

Chief Executive Mike Doustdar’s comments come amid sector focus on M&A and after Novo Nordisk made two disclosures in recent days on its future pipeline that disappointed investors.

AstraZeneca (NASDAQ: AZN) and Bristol Myers Squibb (NYSE: BMY) are the two directly affected public companies; AZN bears the most immediate price risk given it absorbed a roughly 9% single-day selloff on Monday when the merger speculation first emerged, while BMY shareholders were widely viewed as the primary beneficiaries of any combination.

Revenue rose 92% and beat estimates in the first report as a public company

The brand, which has faced many food safety scares over the years, said its ingredient traceability system identified a batch of peppers that may have been contaminated.

Devon Energy reported second-quarter net earnings of $1.9 billion as production reached the upper end of its forecast following the completion of its merger with Coterra Energy.

Is Chipotle facing another food safety crisis?

Caption: Chipotle is removing jalapeños from its menu in Minnesota after potentially being linked to the Salmonella outbreak, according to reports. 🌶️ The stock dipped nearly 9% following the news on Tuesday. Explore more premium news and analysis on Chipotle in AlphaSpace:

Paramount CEO David Ellison said Tuesday that the legal battle over his proposed multibillion-dollar takeover of Warner Bros.Ellison's Paramount Skydance agreed late last month to delay its $110 billion merger with Warner Bros.

IREN acquired software firm Mirantis for $625 million in an all-stock deal, with Mirantis operating as a standalone subsidiary that continues serving its existing customers while IREN taps it for…

Shares plunged 10% after reports tied a food-safety issue to produce at multiple locations, on Aug. 4, 2026.

Gilead Sciences posts higher revenue as its market-leading HIV drug portfolio continues to drive growth.

Chipotle Mexican Grill’s stock is taking a hit after the chain pulled ingredients tied to a Salmonella outbreak.

Yahoo Finance Senior Reporter Brooke DiPalma and Market Domination host Josh Lipton take a closer look at one of Tuesday's trending stories: Chipotle (CMG) pulling its jalapeños due to salmonella concerns. Watch the video above to learn more. Yahoo Finance's AlphaSpace is a premium investment platform that combines data, charting, news, analysis, and more to help retail investors understand markets.

Another foodborne illness outbreak spooked investors.

Chipotle Mexican Grill has pulled jalapeños from several Minnesota restaurants following a state Salmonella outbreak that has infected more than 100 people.

A jalapeño recall, a decade-old reputation problem and a nationwide parasite outbreak are colliding at the worst possible moment for America’s burrito supply chain

Minnesota officials said Chipotle has fully cooperated with the investigation and they are no longer concerned about continued exposure.

Flag Ship Acquisition (NASDAQ:ETHZ) executives, speaking during a Forum Markets presentation hosted by Force Family Office, outlined a strategy centered on acquiring cash-generating real-world assets while maintaining the option to fractionalize and tokenize those assets as the market develops. Joh

(Bloomberg) -- Chipotle Mexican Grill Inc. removed jalapeños from multiple stores in Minnesota after learning the peppers may be linked to a salmonella outbreak in the state that’s sickened 110 people.Most Read from BloombergBeer Dynasty Families Sell €731 Million Stake in AB InBevChina’s AI Blitz Creates ‘Death Zone’ for Rival US Model MakersTaco Bell Met With Michigan on Parasite Weeks Before RecallApple’s New CEO Taps Retired Hardware Executive for Management TeamQatar, Bessent Signal Progres

The acquisition, which was first announced in June, brings Vibe.co into Walmart Connect, Walmart's connected TV advertising platform.

SRX Global (AMEX:SRXH) disclosed an investment in Vistagen Therapeutics (NASDAQ:VTGN) and said it intends to engage with the company’s leadership and board on potential shareholder value initiatives. Key Investor TakeawaysSRX Global (AMEX:SRXH) acquired a stake in Vistagen Therapeutics (NASDAQ:VTGN).

Citi has told clients that a large chunk of deal risk is already in AstraZeneca PLC's (LSE:AZN, NASDAQ:AZN) share price after Monday's sharp fall, while Deutsche Bank sees clear parallels with the drugmaker's Alexion acquisition five years ago. The two notes are the second-day response to a...

Hims and Hers has 2.6 million subscribers, a battered stock price, and a CEO buying shares instead of signaling an exit. That combination puts a very specific list of giants on alert, and only one of them is a clean fit.

Ex-Uber founder and CEO Travis Kalanick is back in the ride-hail business — but this time in the skies.

Ex-Uber founder and CEO Travis Kalanick is back in the ride-hail business — but this time in the skies.

IREN now controls more of the stack between its data centers and customer workloads, extending its AI cloud platform into orchestration and enterprise support.

The pharma giant now expects adjusted earnings of $2.66 to $2.76 per share, down from a prior range of $5.04 to $5.16

Even if a megamerger fails to materialize, investors stand to benefit from a wave of M&A activity in the biopharma sector.